SEC Filing · SCHEDULE 13G/A
Traws Pharma, Inc.
TRAWNASDAQEQUITYCurrent
SEC Filing
Company context
Pharma, Inc. Traws Pharma is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. Traws integrates antiviral drug development, medical intelligence and regulatory strategy to meet real world challenges in the treatment of viral diseases. The Company is advancing novel investigational oral small molecule antiviral agents that have potent activity against difficult to treat or resistant virus strains that threaten human health including seasonal influenza and H5N1 bird flu, negative-strand RNA viruses including Hantavirus, Ebola Virus Disease, Lassa Fever and COVID-19/Long COVID.
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗